NCT01881503
Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia
Enrolling by Invitation
NAAges 18–80InterventionalTreatmentEnglewood Hospital and Medical CenterInvestigator-initiated
~50 participants
Updated 2025-04-13 on ClinicalTrials.gov
What's tested:HBOC-201
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
survival
Measured over 1 week
Conditions
Where it's being run
1 sites across 1 statesNew Jersey1
Study leadership
- Carmine Gianatiempo, MD · PRINCIPAL_INVESTIGATOR · Englewood Hospital and Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- survival1 week
subjects will receive HBOC-201 to treat life-threatening anemia